Innovation and Exploitation Manager

Dr. Michael Harder (Partner 2, corlife) will serve as innovation and exploitation manager for ARISE with the task of ensuring a systematic and sufficient exploitation of the project results during the lifetime of the project. As the project’s primary goal is to evaluate the safety of an existing innovative human tissue product in the clinic and not technical development, the generation of new IP leading to new products is not expected. However, this does not exclude the possibility of improved processes or surgical techniques and both the Innovation and Exploitation Manager and the Clinical Study Director will monitor any relevant developments with the support of the SC. A plan for dissemination and exploitation will be developed in WP6 and shall be regularly updated with the input of all partners involved in the project.